People channel feed

Af­ter a year of big ad­vances, As­traZeneca CEO Pas­cal So­ri­ot takes home a ma­jor-league pay pack­age

6 years ago
Deals

Stan­ford stem cell pi­o­neer nets $194M from Gilead-Forty Sev­en buy­out

6 years ago
Deals

Ver­sant woos Mor­phoSys' ex-CSO to its boom­ing dis­cov­ery en­gine, with big plans for new star­tups

6 years ago
Financing

Nine new coro­n­avirus cas­es are tied to the Bio­gen out­break — as in­fec­tions spread to 'close con­tact­s'

6 years ago
Pharma
Coronavirus

Macro­Gen­ics los­es CMO Jon Wig­gin­ton as com­mer­cial­iza­tion looms

6 years ago
R&D

Af­ter a trend­set­ting role in glob­al biotech ven­ture in­vest­ing, David Mott parts ways with NEA

6 years ago
Financing

GSK's Em­ma Walm­s­ley award­ed £8.4M pay pack­age af­ter £2.5M rise, fi­nal­ly catch­ing up with fel­low phar­ma CEOs

6 years ago

AM­AG CMO hits the ex­it just as biotech search­es for new CEO to right a ship rocked by Mak­e­na con­tro­ver­sy

6 years ago
Pharma

Ver­tex, Seat­tle Ge­net­ics, Alpine with­draw from in­vestor con­fer­ence as biotechs brace for coro­n­avirus

6 years ago
Coronavirus

As US di­als up coro­n­avirus re­sponse, BIO taps Vir's George Scan­gos to head com­mit­tee co­or­di­nat­ing in­dus­try ef­forts

6 years ago
Coronavirus

Scoop: Cor­po­rate de­vel­op­ment chief hits the ex­it at Bio­gen as ad­u­canum­ab jit­ters roll on

6 years ago
R&D

Turn­ing fo­cus to clin­i­cal work, Ve­rastem ax­es 31 jobs, scales back can­cer drug pro­mo­tion af­ter dis­ap­point­ing sales

6 years ago
R&D

Ex-Sanofi chief Olivi­er Brandi­court, cur­rent Black­stone ad­vi­sor, jumps on Al­ny­lam board

6 years ago

Spark los­es an­oth­er top ex­ec in the wake of $4.3B takeover by Roche — re­port

6 years ago
Cell/Gene Tx

Gene ther­a­py pi­o­neer Kathy High has left Spark af­ter com­plet­ing $4.3B union with Roche

6 years ago
Cell/Gene Tx

Fresh off $100M round, GV-backed re­al-world da­ta start­up woos Duke re­searcher as CMO

6 years ago
Startups

Mer­ck los­es its chief dig­i­tal of­fi­cer, spot­light­ing tal­ent hunt for the hottest ti­tle in Big Phar­ma

6 years ago
R&D

Eli Lil­ly vet Ker­ry Blan­chard takes the helm at one of Chi­na's top deal­mak­ers, steer­ing to­ward first ap­provals

6 years ago
China

Biotech CEO who lied about cur­ing his own paral­y­sis sen­tenced to 7 years in jail

6 years ago

Carl June on CRISPR, CAR–T and how the Viet­nam War dropped him in­to med­i­cine

6 years ago
R&D
In Focus

No­var­tis chris­tens new UK HQ in West Lon­don, kick­ing off its big in­clisir­an CV tri­al

6 years ago
R&D
Pharma

A crash­ing Wave takes out the bud­get ax to chop staff, aban­don­ing work on Duchenne MD in re­struc­tur­ing

6 years ago
R&D

Scott Got­tlieb adds one more high-pro­file board seat to the post-FDA re­sume. And it’s an­oth­er plum as­sign­ment

6 years ago

Ian Read adds a new post to his grow­ing ros­ter of post-Pfiz­er po­si­tions — and this one pays well

6 years ago
R&D
First page Previous page 70717273747576 Next page Last page
A service from the Financial Times